Jonathan J. Hogan

795 total citations
9 papers, 81 citations indexed

About

Jonathan J. Hogan is a scholar working on Nephrology, Pulmonary and Respiratory Medicine and Molecular Biology. According to data from OpenAlex, Jonathan J. Hogan has authored 9 papers receiving a total of 81 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Nephrology, 5 papers in Pulmonary and Respiratory Medicine and 3 papers in Molecular Biology. Recurrent topics in Jonathan J. Hogan's work include Vasculitis and related conditions (5 papers), Renal Diseases and Glomerulopathies (5 papers) and Amyloidosis: Diagnosis, Treatment, Outcomes (2 papers). Jonathan J. Hogan is often cited by papers focused on Vasculitis and related conditions (5 papers), Renal Diseases and Glomerulopathies (5 papers) and Amyloidosis: Diagnosis, Treatment, Outcomes (2 papers). Jonathan J. Hogan collaborates with scholars based in United States, Canada and United Kingdom. Jonathan J. Hogan's co-authors include Jai Radhakrishnan, Vijay Bhoj, Abdallah Sassine Geara, Gerald B. Appel, Prince Mohan, Patrick H. Nachman, Jürgen Floege, Sydney Tang, Jack F.M. Wetzels and Michael Cheung and has published in prestigious journals such as Journal of the American Society of Nephrology, American Journal of Kidney Diseases and Clinical Journal of the American Society of Nephrology.

In The Last Decade

Jonathan J. Hogan

8 papers receiving 75 citations

Peers

Jonathan J. Hogan
Christine B. Sethna United States
Samir V. Parikh United States
M. Dinic France
E Honsová Czechia
Sheng Kuo United States
Alma Idrizi Albania
Christine B. Sethna United States
Jonathan J. Hogan
Citations per year, relative to Jonathan J. Hogan Jonathan J. Hogan (= 1×) peers Christine B. Sethna

Countries citing papers authored by Jonathan J. Hogan

Since Specialization
Citations

This map shows the geographic impact of Jonathan J. Hogan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jonathan J. Hogan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jonathan J. Hogan more than expected).

Fields of papers citing papers by Jonathan J. Hogan

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jonathan J. Hogan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jonathan J. Hogan. The network helps show where Jonathan J. Hogan may publish in the future.

Co-authorship network of co-authors of Jonathan J. Hogan

This figure shows the co-authorship network connecting the top 25 collaborators of Jonathan J. Hogan. A scholar is included among the top collaborators of Jonathan J. Hogan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jonathan J. Hogan. Jonathan J. Hogan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

9 of 9 papers shown
1.
Zee, Jarcy, et al.. (2025). Noninvasive Diagnostic Strategies for Membranous Nephropathy in the Nephrotic Syndrome Study Network. Clinical Journal of the American Society of Nephrology. 20(5). 697–705. 1 indexed citations
2.
Sheikh, Saira Z., Vimal K. Derebail, Gaurav Gulati, et al.. (2025). RESET SLE: CLINICAL TRIAL EVALUATING CABA-201, A FULLY HUMAN, AUTOLOGOUS 4-1BB ANTI-CD19 CAR T CELL THERAPY IN NONRENAL SLE AND LUPUS NEPHRITIS. The Journal of Rheumatology. 52(Suppl 1). 27–27.
3.
Geara, Abdallah Sassine, Vijay Bhoj, & Jonathan J. Hogan. (2021). Bortezomib Treatment for Refractory PLA2R-Positive Membranous Nephropathy. PubMed. 1(1). 40–43. 23 indexed citations
4.
Canney, Mark, et al.. (2021). Patients with Glomerular Disease Are at Very High Risk of TB Infection Compared to the General Population. Journal of the American Society of Nephrology. 32(10S). 490–490. 1 indexed citations
5.
Rovin, Brad H., Dawn J. Caster, Daniel C. Cattran, et al.. (2021). Management and treatment of glomerular diseases (part 2): Conclusions From A Kidney Disease: Improving Global Outcomes (KDIGO) controversies conference. Nephrology (Saint-Petersburg). 25(1). 96–119. 2 indexed citations
6.
Floege, Jürgen, Sean J. Barbour, Daniel Cattran, et al.. (2020). Management and treatment of glomerular diseases (part 1): conclusions from a kidney disease: improving global outcomes (KDIGO) controversies conference. Nephrology (Saint-Petersburg). 24(2). 22–41. 11 indexed citations
7.
Stokes, Michael B., et al.. (2016). Atypical Antiglomerular Basement Membrane Disease With IgG1-κ Staining. Kidney International Reports. 2(1). 80–83. 3 indexed citations
8.
Hogan, Jonathan J., Prince Mohan, & Gerald B. Appel. (2013). Diagnostic Tests and Treatment Options in Glomerular Disease: 2014 Update. American Journal of Kidney Diseases. 63(4). 656–666. 14 indexed citations
9.
Hogan, Jonathan J. & Jai Radhakrishnan. (2012). The Assessment and Importance of Hypertension in the Dental Setting. Dental Clinics of North America. 56(4). 731–745. 26 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026